Siirry päänavigointiin Siirry hakuun Siirry pääsisältöön

Invasion/chemotaxis- and extravasation-chip models for breast cancer bone metastasis

Tutkimustuotos: ArtikkeliTieteellinenvertaisarvioitu

4 Sitaatiot (Scopus)
9 Lataukset (Pure)

Abstrakti

Bone is one of the most frequently targeted organs in metastatic cancers including the breast. Breast cancer bone metastasis often results in devastating outcomes as limited treatment options are currently available. Therefore, innovative methods are needed to provide earlier detection and thus better treatment and prognosis. Here, we present a new approach to model bone-like microenvironments to detect invasion and extravasation of breast cancer cells using invasion/chemotaxis (IC-) and extravasation (EX-) chips, respectively. Our results show that the behaviors of MDA-MB-231 breast cancer cells on IC- and EX-chip models correlate with their in vivo metastatic potential. Our culture model constitutes cell lines representing osteoblasts, bone marrow stromal cells, and monocytes embedded in three-dimensional (3D) collagen I-based extracellular matrices of varying composition and stiffness. We show that collagen I offers a better bone-like environment for bone cells and matrix composition and stiffness regulate the invasion of breast cancer cells. Using in situ contactless rheological measurements under cell culture conditions, we show that the presence of cells increased the stiffness values of the matrices up to 1200 Pa when monitored for five days. This suggests that the cellular composition has a significant effect on regulating matrix mechanical properties, which in turn contribute to the invasiveness. The platforms we present here enable the investigation of the underlying molecular mechanisms in breast cancer bone metastasis and provide the groundwork of developing preclinical tools for the prediction of bone metastasis risk.

AlkuperäiskieliEnglanti
Artikkelie0309285
JulkaisuPLoS ONE
Vuosikerta19
Numero10
DOI - pysyväislinkit
TilaJulkaistu - lokak. 2024
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Rahoitus

O.Y.O and D.P.O. received the funding from the Scientific and Technological Research Council of Turkiye (TUBITAK), 115E057 N.N. received the funding from the Research Council of Finland (No. 352900) B.F.Y. received a short-term fellowship from the European Molecular Biology Organization (EMBO), 8509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Joan Massagu\u00E9 and Memorial Sloan Kettering Cancer Center for providing MDA-MB-231 LM2 and MDA-MB-231 1833-BoM; Engin \u00D6z\u00E7ivici for providing hFOB 1.19, SaOs-2, and D1 ORL UVA; H. Cumhur Tekin for providing U937 cell lines.

RahoittajatRahoittajan numero
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu115E057
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Research Council of Finland352900
Research Council of Finland
European Molecular Biology OrganizationMDA-MB-231 1833-BoM, SaOs-2
European Molecular Biology Organization

    YK:n kestävän kehityksen tavoitteet

    Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

    1. SDG 3 – Hyvä terveys ja hyvinvointi
      SDG 3 – Hyvä terveys ja hyvinvointi

    Julkaisufoorumi-taso

    • Jufo-taso 1

    !!ASJC Scopus subject areas

    • General

    Sormenjälki

    Sukella tutkimusaiheisiin 'Invasion/chemotaxis- and extravasation-chip models for breast cancer bone metastasis'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

    Siteeraa tätä